DOBAK JOHN DANIEL has a total of 24 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2006. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and China. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and medical technology are NEOTHETICS INC, BIONOOX SUISSE SA and JENIVISION INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 12 | |
#2 | WIPO (World Intellectual Property Organization) | 5 | |
#3 | China | 2 | |
#4 | EPO (European Patent Office) | 2 | |
#5 | Australia | 1 | |
#6 | Canada | 1 | |
#7 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Medical technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Specific use of cosmetics | |
#4 | Electrotherapy | |
#5 | Diagnosis and surgery |
# | Name | Total Patents |
---|---|---|
#1 | Dobak John Daniel | 24 |
#2 | Locke Kenneth Walter | 5 |
Publication | Filing date | Title |
---|---|---|
EP3744330A1 | Reduction of adipose tissue | |
US2016045452A1 | Sodium tetradecyl sulfate formulations for treatment of adipose tissue | |
US2016045416A1 | Ethanolamine oleate formulations for treatment of adipose tissue | |
WO2012071480A2 | Lipophilic glucocorticosteroid monotherapeutic formulations and methods for the cosmetic treatment of adiposity and contour bulging | |
US2012004564A1 | Devices and method for accelerometer-based characterization of cardiac synchrony and dyssynchrony | |
US2011130373A1 | Methods for administration and formulations for the treatment of regional adipose tissue |